在耐火性皮肤伪淋巴瘤中Upadacitinib:一个病例报告
Elisabetta Danese1, Tea Curic1, Francesco Bellinato1
1Section of Dermatology and Venereology, Department of Medicine, University of Verona, Italy.
SAGE open medical case reports
|June 23, 2025
概括
皮肤伪淋巴瘤是一种良性淋巴增殖性疾病,治疗可能具有挑战性. 这一案例突出显示了对IgG4相关的不耐药面部伪淋巴瘤的成功上达西替尼治疗.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 皮肤伪淋巴瘤是一种良性淋巴增殖性疾病,涉及B细胞,T细胞或两者.
- 原因包括注射物质,纹身,药物或昆虫咬伤,但它通常是特异性的.
- 缺乏治疗指导方针,有些病例抵抗常规疗法.
相关概念视频
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...


